Taro Completes Acquisition Of Alchemee

Feb 28, 2022•over 3 years ago

Acquiring Company

Taro

Acquired Company

Alchemee

ManufacturingHealth CareGovernment And MilitarySustainabilityScience And Engineering

Description

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro”) today announced the completion of its acquisition of Alchemee, formerly The Proactiv Company (TPC), from Galderma. The acquisition includes Alchemee’s business and assets worldwide, including the Proactiv® brand.

Company Information

Company

Taro

About

Taro Pharmaceutical Industries Ltd. is a multinational, science-based pharmaceutical company, dedicated to meeting the needs of its customers through the discovery, development, manufacturing and marketing of the highest quality healthcare products. For further information on Taro Pharmaceutical Industries Ltd., please visit the Company’s website at www.taro.com.

DealWatch™ Score

High M&A Activity

M&A Opportunity Analysis

Get personalized insights on M&A opportunities

M&A Insights

Based on deal data

Integration timeline

70% of M&A integrations take 12-24 months to complete

Tech stack consolidation

83% of merged companies consolidate technology vendors within first year

Post-acquisition investment

Companies increase IT spending by 23% on average after acquisitions

Success factor